Kenji Andò
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cardiac pacing and defibrillation studies
- Internal Medicine top 1%
Papers in
-
- Cardiac Valve Diseases and Treatments 94
- Cardiac pacing and defibrillation studies 46
- Antiplatelet Therapy and Cardiovascular Diseases 42
- Atrial Fibrillation Management and Outcomes 40
- Heart Failure Treatment and Management 39
- Surgery 178
- Coronary Interventions and Diagnostics 102
- Peripheral Artery Disease Management 61
- Co-authors
- Yoshimitsu Soga (84 shared papers)Takeshi Kimura (67 shared papers)Kyohei Yamaji (56 shared papers)Shinichi Shirai (81 shared papers)Masakiyo Nobuyoshi (36 shared papers)Shoichi Kuramitsu (45 shared papers)Yoshihisa Nakagawa (40 shared papers)Kazushige Kadota (47 shared papers)
- Journals
- Circulation Journal (58 papers)The American Journal of Cardiology (32 papers)Cardiovascular Intervention and Therapeutics (24 papers)Journal of the American College of Cardiology (20 papers)Circulation Cardiovascular Interventions (19 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kenji Andò
446 papers receiving 8.6k citations
Kenji Andò's Hit Papers
Peers
Comparison fields: 5 of 130
- Cardiology and Cardiovascular Medicine 5.1k
- Internal Medicine 332
- Surgery 3.4k
- Radiology, Nuclear Medicine and Imaging 752
- Pulmonary and Respiratory Medicine 872
Countries citing papers authored by Kenji Andò
This map shows the geographic impact of Kenji Andò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Andò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Andò more than expected).
Fields of papers citing papers by Kenji Andò
This network shows the impact of papers produced by Kenji Andò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Andò. The network helps show where Kenji Andò may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenji Andò, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 480 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI Hit paper breakdown → | 2019 | 633 |
| 2 | 2015 | 250 | |
| 3 | Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Hit paper breakdown → | 2022 | 224 |
| 4 | 2018 | 214 | |
| 5 | P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials Hit paper breakdown → | 2021 | 180 |
| 6 | 2018 | 150 | |
| 7 | 2014 | 147 | |
| 8 | 2021 | 146 | |
| 9 | 2019 | 142 | |
| 10 | 2021 | 128 | |
| 11 | 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis Hit paper breakdown → | 2023 | 125 |
| 12 | 2016 | 117 | |
| 13 | 2019 | 111 | |
| 14 | 2011 | 107 | |
| 15 | 2018 | 106 | |
| 16 | 2015 | 102 | |
| 17 | 1990 | 99 | |
| 18 | An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial Hit paper breakdown → | 2023 | 98 |
| 19 | 2017 | 94 | |
| 20 | 2017 | 93 |
About Kenji Andò
Kenji Andò is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 480 papers that have together received 8.9k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (102 papers), Cardiac Valve Diseases and Treatments (94 papers), Peripheral Artery Disease Management (61 papers), Cardiac pacing and defibrillation studies (46 papers), Antiplatelet Therapy and Cardiovascular Diseases (42 papers), Atrial Fibrillation Management and Outcomes (40 papers), Heart Failure Treatment and Management (39 papers) and Infective Endocarditis Diagnosis and Management (32 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.1k citations), Internal Medicine (332 citations), Surgery (3.4k citations), Radiology, Nuclear Medicine and Imaging (752 citations) and Pulmonary and Respiratory Medicine (872 citations). Kenji Andò has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yoshimitsu Soga, Takeshi Kimura, Kyohei Yamaji, Shinichi Shirai, Masakiyo Nobuyoshi, Shoichi Kuramitsu, Yoshihisa Nakagawa, Kazushige Kadota, Hiroki Shiomi and Takeshi Morimoto. Their work appears in journals such as Circulation Journal, The American Journal of Cardiology, Cardiovascular Intervention and Therapeutics, Journal of the American College of Cardiology and Circulation Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.